• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脊髓性肌萎缩症疲劳度:耐力穿梭测试的有效性和可靠性。

Fatigability in spinal muscular atrophy: validity and reliability of endurance shuttle tests.

机构信息

Wilhelmina Children's Hospital, University Medical Center Utrecht, Child Development and Exercise Center, Lundlaan 6, Internal mailbox no. KB 02.056.0, Utrecht, 3508, AB, The Netherlands.

Research Group Lifestyle and Health, HU University of Applied Health Sciences Utrecht, Utrecht, The Netherlands.

出版信息

Orphanet J Rare Dis. 2020 Mar 23;15(1):75. doi: 10.1186/s13023-020-1348-2.

DOI:10.1186/s13023-020-1348-2
PMID:32293503
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7092552/
Abstract

BACKGROUND

To determine construct validity and test-retest reliability of Endurance Shuttle Tests as outcome measures for fatigability of remaining motor functions in children and adults with Spinal Muscular Atrophy (SMA) across the severity spectrum.

RESULTS

We assessed the Endurance Shuttle - Nine Hole Peg Test (ESNHPT), - Box and Block Test (ESBBT) and - Walk Test (ESWT) in 61 patients with SMA types 2-4, 25 healthy controls (HC) and 15 disease controls (DC). Convergent validity, discriminative validity and test-retest reliability were investigated. Additionally, we compiled the Endurance Shuttle Combined Score (ESTCS) by selecting the most relevant endurance test of each individual. 54, 70 and 73% of patients with SMA demonstrated increased fatigability on the ESNHPT, ESBBT and the ESWT. Endurance response in SMA was characterized by a decrease in muscle strength, an increase in muscle fatigue and an increase in motor adaptions, thereby confirming convergent validity. Patients with SMA showed increased drop-out rates and a shorter endurance time compared to HC and DC demonstrating good discriminative validity. Test-retest reliability was moderate to excellent (ICC's ranging from .78 to .91) with a trend towards better performance on retest. The ESTCS increased sample size and drop-out rate up to 100 and 85%.

CONCLUSIONS

Fatigability is an important additional dimension of physical impairments across the severity spectrum in children and adults with SMA. The EST's are reliable and valid to document fatigability of walking, proximal- and distal arm function in SMA and thus are promising outcome measures for use in clinical trials.

摘要

背景

为了确定耐力穿梭测试在脊髓性肌萎缩症(SMA)患者中的构建效度和重测信度,作为评估不同严重程度患儿和成年患者剩余运动功能疲劳的结果测量指标。

结果

我们评估了耐力穿梭-九孔钉测试(ESNHPT)、-方块和积木测试(ESBBT)和-行走测试(ESWT)在 61 例 SMA 2-4 型患者、25 名健康对照(HC)和 15 名疾病对照(DC)中的应用。研究了其会聚效度、判别效度和重测信度。此外,我们通过选择每个个体最相关的耐力测试,编制了耐力穿梭综合评分(ESTCS)。54%、70%和 73%的 SMA 患者在 ESNHPT、ESBBT 和 ESWT 上表现出疲劳增加。SMA 的耐力反应特征为肌肉力量下降、肌肉疲劳增加和运动适应增加,从而确认了会聚效度。与 HC 和 DC 相比,SMA 患者的退出率增加,耐力时间更短,具有良好的判别效度。重测信度为中等至极好(ICC 范围为.78 至.91),表现出重测时的性能有改善的趋势。ESTCS 提高了样本量和退出率,达到 100%和 85%。

结论

疲劳是儿童和成年 SMA 患者严重程度范围内身体损伤的一个重要附加维度。EST 可靠且有效,可用于记录 SMA 患者行走、近端和远端手臂功能的疲劳,因此是临床试验中很有前途的结果测量指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df24/7092552/fbd380d78f39/13023_2020_1348_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df24/7092552/31faec9547f4/13023_2020_1348_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df24/7092552/fbd380d78f39/13023_2020_1348_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df24/7092552/31faec9547f4/13023_2020_1348_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df24/7092552/fbd380d78f39/13023_2020_1348_Fig2_HTML.jpg

相似文献

1
Fatigability in spinal muscular atrophy: validity and reliability of endurance shuttle tests.脊髓性肌萎缩症疲劳度:耐力穿梭测试的有效性和可靠性。
Orphanet J Rare Dis. 2020 Mar 23;15(1):75. doi: 10.1186/s13023-020-1348-2.
2
Assessment of fatigability in patients with spinal muscular atrophy: development and content validity of a set of endurance tests.脊髓性肌萎缩症患者疲劳性评估:一组耐力测试的开发与内容效度
BMC Neurol. 2019 Feb 9;19(1):21. doi: 10.1186/s12883-019-1244-3.
3
Protocol for a phase II, monocentre, double-blind, placebo-controlled, cross-over trial to assess efficacy of pyridostigmine in patients with spinal muscular atrophy types 2-4 (SPACE trial).一项评估吡啶斯的明对2-4型脊髓性肌萎缩症患者疗效的II期、单中心、双盲、安慰剂对照、交叉试验方案(SPACE试验)。
BMJ Open. 2018 Jul 30;8(7):e019932. doi: 10.1136/bmjopen-2017-019932.
4
A continuous repetitive task to detect fatigability in spinal muscular atrophy.一项用于检测脊髓性肌萎缩症疲劳性的连续重复任务。
Orphanet J Rare Dis. 2018 Sep 12;13(1):160. doi: 10.1186/s13023-018-0904-5.
5
Correlates of Fatigability in Patients With Spinal Muscular Atrophy.脊髓性肌萎缩症患者疲劳的相关因素。
Neurology. 2021 Feb 9;96(6):e845-e852. doi: 10.1212/WNL.0000000000011230. Epub 2020 Nov 20.
6
Respiratory muscle fatigability in patients with spinal muscular atrophy.脊髓性肌萎缩症患者的呼吸肌疲劳性。
Pediatr Pulmonol. 2022 Dec;57(12):3050-3059. doi: 10.1002/ppul.26133. Epub 2022 Sep 14.
7
Six-minute walk test is reliable and valid in spinal muscular atrophy.六分钟步行试验在脊髓性肌萎缩症中具有可靠性和有效性。
Muscle Nerve. 2016 Nov;54(5):836-842. doi: 10.1002/mus.25120. Epub 2016 May 13.
8
Motor unit reserve capacity in spinal muscular atrophy during fatiguing endurance performance.在疲劳耐力表现期间,脊髓性肌萎缩症中的运动单位储备能力。
Clin Neurophysiol. 2021 Mar;132(3):800-807. doi: 10.1016/j.clinph.2020.11.044. Epub 2021 Jan 28.
9
Objective measurement of oral function in adults with spinal muscular atrophy.成人脊髓性肌萎缩症口腔功能的客观测量。
Orphanet J Rare Dis. 2023 May 3;18(1):103. doi: 10.1186/s13023-023-02688-4.
10
Performance of the timed "up & go" test in spinal muscular atrophy. timed "up & go" 测试在脊髓性肌萎缩症中的表现。
Muscle Nerve. 2014 Aug;50(2):273-7. doi: 10.1002/mus.24153. Epub 2014 May 12.

引用本文的文献

1
Fatigue in Spinal Muscular Atrophy: a fundamental open issue.脊髓性肌萎缩症中的疲劳:一个基本的未解决问题。
Acta Myol. 2024 Mar 31;43(1):1-7. doi: 10.36185/2532-1900-402. eCollection 2024.
2
Walking test outcomes in adults with genetic neuromuscular diseases: a systematic literature review of their measurement properties.成人遗传性神经肌肉疾病行走测试结果:测量特性的系统文献回顾。
Eur J Phys Rehabil Med. 2024 Apr;60(2):257-269. doi: 10.23736/S1973-9087.24.08095-X. Epub 2024 Feb 1.
3
Assessing the Assisted Six-Minute Cycling Test as a Measure of Endurance in Non-Ambulatory Patients with Spinal Muscular Atrophy (SMA).

本文引用的文献

1
Assessment of fatigability in patients with spinal muscular atrophy: development and content validity of a set of endurance tests.脊髓性肌萎缩症患者疲劳性评估:一组耐力测试的开发与内容效度
BMC Neurol. 2019 Feb 9;19(1):21. doi: 10.1186/s12883-019-1244-3.
2
A continuous repetitive task to detect fatigability in spinal muscular atrophy.一项用于检测脊髓性肌萎缩症疲劳性的连续重复任务。
Orphanet J Rare Dis. 2018 Sep 12;13(1):160. doi: 10.1186/s13023-018-0904-5.
3
Patient Reported Impact of Symptoms in Spinal Muscular Atrophy (PRISM-SMA).
评估辅助六分钟骑行测试作为非行走型脊髓性肌萎缩症(SMA)患者耐力的一项指标。
J Clin Med. 2023 Dec 8;12(24):7582. doi: 10.3390/jcm12247582.
4
Measuring Fatigue and Fatigability in Spinal Muscular Atrophy (SMA): Challenges and Opportunities.测量脊髓性肌萎缩症(SMA)中的疲劳和易疲劳性:挑战与机遇
J Clin Med. 2023 May 14;12(10):3458. doi: 10.3390/jcm12103458.
5
Objective measurement of oral function in adults with spinal muscular atrophy.成人脊髓性肌萎缩症口腔功能的客观测量。
Orphanet J Rare Dis. 2023 May 3;18(1):103. doi: 10.1186/s13023-023-02688-4.
6
Longitudinal prospective cohort study to assess peripheral motor function with extensive electrophysiological techniques in patients with Spinal Muscular Atrophy (SMA): the SMA Motor Map protocol.采用广泛的电生理技术对脊髓性肌萎缩症(SMA)患者进行纵向前瞻性队列研究,以评估周围运动功能:SMA 运动图方案。
BMC Neurol. 2023 Apr 24;23(1):164. doi: 10.1186/s12883-023-03207-5.
7
Translating fatigability in spinal muscular atrophy to clinical trials and management.将脊髓性肌萎缩症中的易疲劳性转化用于临床试验及管理。
Muscle Nerve. 2023 Jul;68(1):6-7. doi: 10.1002/mus.27831. Epub 2023 Apr 22.
8
Measuring objective fatigability and autonomic dysfunction in clinical populations: How and why?测量临床人群的客观疲劳性和自主神经功能障碍:方法与原因?
Front Sports Act Living. 2023 Mar 30;5:1140833. doi: 10.3389/fspor.2023.1140833. eCollection 2023.
9
The RESISTANT study (Respiratory Muscle Training in Patients with Spinal Muscular Atrophy): study protocol for a randomized controlled trial.RESISTANT 研究(脊髓性肌萎缩症患者呼吸肌训练):一项随机对照试验的研究方案。
BMC Neurol. 2023 Mar 23;23(1):118. doi: 10.1186/s12883-023-03136-3.
10
Pathophysiology and Management of Fatigue in Neuromuscular Diseases.神经肌肉疾病中疲劳的病理生理学和管理。
Int J Mol Sci. 2023 Mar 5;24(5):5005. doi: 10.3390/ijms24055005.
脊髓性肌萎缩症患者症状影响报告(PRISM-SMA)。
Neurology. 2018 Sep 25;91(13):e1206-e1214. doi: 10.1212/WNL.0000000000006241. Epub 2018 Aug 24.
4
Prospective and longitudinal natural history study of patients with Type 2 and 3 spinal muscular atrophy: Baseline data NatHis-SMA study.2 型和 3 型脊髓性肌萎缩症患者的前瞻性和纵向自然史研究:NatHis-SMA 研究的基线数据。
PLoS One. 2018 Jul 26;13(7):e0201004. doi: 10.1371/journal.pone.0201004. eCollection 2018.
5
Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy.依库珠单抗治疗晚发性脊髓性肌萎缩症的疗效观察:一项随机、双盲、安慰剂对照 3 期试验
N Engl J Med. 2018 Feb 15;378(7):625-635. doi: 10.1056/NEJMoa1710504.
6
Muscle strength and motor function throughout life in a cross-sectional cohort of 180 patients with spinal muscular atrophy types 1c-4.180 例脊髓性肌萎缩症 1c-4 型患者的横断面队列研究中贯穿一生的肌肉力量和运动功能。
Eur J Neurol. 2018 Mar;25(3):512-518. doi: 10.1111/ene.13534. Epub 2018 Feb 2.
7
Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy.依库珠单抗治疗婴儿型脊髓性肌萎缩症的疗效观察
N Engl J Med. 2017 Nov 2;377(18):1723-1732. doi: 10.1056/NEJMoa1702752.
8
Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy.脊髓性肌萎缩症的单剂量基因治疗。
N Engl J Med. 2017 Nov 2;377(18):1713-1722. doi: 10.1056/NEJMoa1706198.
9
Therapeutic strategies for spinal muscular atrophy: SMN and beyond.脊髓性肌萎缩症的治疗策略:生存运动神经元蛋白及其他
Dis Model Mech. 2017 Aug 1;10(8):943-954. doi: 10.1242/dmm.030148.
10
A qualitative study of perceptions of meaningful change in spinal muscular atrophy.一项关于脊髓性肌萎缩症中有意义变化认知的定性研究。
BMC Neurol. 2017 Apr 4;17(1):68. doi: 10.1186/s12883-017-0853-y.